Business Context and Reporting Period
This Form 8-K Current Report was filed by Global Medical REIT Inc. (GMRE) on March 17, 2021, regarding events occurring on March 16, 2021. The filing details the entry into a material definitive agreement for a public equity offering.
Key Financial Metrics and Transaction Details
- Offering Size: 7,500,000 shares of Common Stock, plus a full exercise of the 30-day option for 1,125,000 additional shares (Total: 8,625,000 shares).
- Public Offering Price: $13.30 per share.
- Price to Company: $12.7015 per share.
- Expected Net Proceeds: Approximately $109.6 million (excluding offering expenses).
- Existing Debt: As of December 31, 2020, the company had $525.2 million in borrowings outstanding under its Credit Facility.
- Credit Facility Structure: $350 million Term Loan (expires August 2023) and $250 million Revolver (expires August 2022, with one-year extension option).
Material Changes and Use of Proceeds
The primary material change is the execution of an Underwriting Agreement to raise capital. The company intends to contribute the net proceeds to its Operating Partnership. The Operating Partnership plans to use these funds to:
- Repay a portion of outstanding indebtedness under the Credit Facility.
- Fund future acquisitions.
- Support other general corporate purposes.
The filing notes that amounts repaid under the Revolver may be re-borrowed in the future to fund the capital program.
Outlook, Risks, and Management Commentary
The offering is expected to close on March 18, 2021. The filing references customary representations, warranties, and indemnification obligations within the Underwriting Agreement. No specific forward-looking financial guidance or risk factors beyond standard underwriting terms are detailed in this specific excerpt.
Key Facts for Investor Verification
- Verify the final closing date and actual net proceeds received after deducting offering expenses.
- Confirm the specific amount of debt repaid from the $109.6 million in proceeds versus amounts allocated to acquisitions.
- Monitor the company's leverage ratio post-repayment to assess the impact on the floating interest rate margin.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific termination provisions and lock-up periods.